Food News and Research

RSS

New initiative to improve children's nutrition education, help them make smarter food choices

A new initiative to improve children's nutrition education and increase the amount of healthy foods available in schools is a collaboration among Penn State researchers; Pennsylvania's Departments of Health, Education, and Agriculture; Pennsylvania food manufacturers and food distributors; and school districts across the state.

16 Jul 2010

Restricting salt intake to 6g per day lowers risk of cardiovascular morbidities

Restricting the amount of sodium chloride in food can lower the risk of cardiovascular morbidities. This is the conclusion that Dieter Klaus and colleagues come to in the current issue of Deutsches -rzteblatt International.

16 Jul 2010

i26 hyperimmune egg balances improper immune inflammatory response

Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body's once-healthy tissues.

16 Jul 2010

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.

16 Jul 2010

Glaxo announces a $2.3 billion in legal liability charges

British pharmaceutical giant GlaxoSmithKline, announced this Thursday that its second-quarter charges related to legal cases involving the two drugs Avandia (diabetes drug) and Paxil (drug for anxiety and depression) would run up to $2.36 billion. Avandia’s use and its potential risk of causing heart problems were being debated this week by an advisory panel to the US Food & Drugs Administration (FDA).

16 Jul 2010

Amnesty International reveals the rotting health care system in North Korea

According to a human rights group, Amnesty International, North Korea is unable to meet up to even the most basic health needs of its population. The report was released this Thursday.

15 Jul 2010

Rapid weight loss the best: Study

Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.

15 Jul 2010

Sepracor to change name to Sunovion Pharmaceuticals

Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd., an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion Pharmaceuticals Inc. in the United States. DSP acquired Sepracor in October 2009 and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010.

15 Jul 2010

First Edition: July 15, 2010

Headlines topping today's news include reports about the White House release of new coverage rules for certain screening tests and other types of preventive care, and calls from the GOP for hearings on Berwick's recess appointment to run Medicare and Medicaid top today's news.

15 Jul 2010

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.

15 Jul 2010

Study looks at trans fat trends in major fast food chains

Five major fast food chains have significantly decreased trans fats in the oils they use to cook food, according to new research from the University of Minnesota School of Public Health.

15 Jul 2010

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

15 Jul 2010

NIH announces 5 more years of funding for Consortium of Food Allergy Research

Today, the National Institutes of Health announce that the Consortium of Food Allergy Research (CoFAR), established in 2005, will be funded for five more years. CoFAR will continue to foster new approaches to prevent and treat food allergies and also expand in scope to include research on the genetic causes underlying food allergy and studies of food allergy-associated eosinophilic gastrointestinal diseases (EGIDs).

15 Jul 2010

Enzyme mTOR regulates autophagy: Study

Cells that consume parts of themselves can stop this process autonomously as well. This was discovered by NWO researcher Judith Klumperman's group, in collaboration with colleagues from the National Institute of Health in Washington. The self-cannibalism is part of the normal digestive process of the cell, but also a survival mechanism in times of famine. This is what makes it difficult for doctors to 'starve out' cancer cells, for instance. The research results were published on 6 June in Nature.

15 Jul 2010

Black tea consumption can pose problems to heavy tea drinkers

Black tea, a Southern staple and the world's most consumed beverage, may contain higher concentrations of fluoride than previously thought, which could pose problems for the heaviest tea drinkers.

15 Jul 2010

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.

15 Jul 2010

Mizzou Advantage researchers examine food-related issues to find solutions for future

Many of society's most challenging health issues, including obesity, nutritional shortages and chronic disease, are related to food. University of Missouri researchers are examining the multiple facets of food and how it impacts our lives - from medicine and research to policy and law to education and business.

15 Jul 2010

Key protein in insulin signaling pathway adds insights into development, aging

What makes a bee grow up to be a queen? Scientists have long pondered this mystery. Now, researchers in the School of Life Sciences at Arizona State University have fit a new piece into the puzzle of bee development. Their work not only adds to understanding about bees, but also adds insights into our own development and aging.

15 Jul 2010

Two patents issued for GlycoMimetics lead drug candidate, related compounds

GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.

15 Jul 2010

Study reveals anti-diabetic properties of cashew seed extract

Cashew seed extract shows promise as an effective anti-diabetic, according to a new study from the University of Montreal (Canada) and the Universit- de Yaound- (Cameroun). Published in the journal Molecular Nutrition & Food Research, the investigation analyzed the reputed health benefits of cashew tree products on diabetes, notably whether cashew extracts could improve the body's response to its own insulin.

15 Jul 2010